Skip to main content
ISSCR 2025 Annual Meeting Main banner

Dhruv Sareen, PhD

Cedars-Sinai Medical Center

Dr. Sareen is the founding executive director and chief biomanufacturing officer of the Cedars-Sinai Biomanufacturing Center (CBC). He has extensive experience with human iPSC-based platform technologies, GMP biomanufacturing, space medicine, mechanistic drug discovery, process development, and translating advanced cell therapies into the clinic. The CBC. He led the establishment of a state-of-the art cGMP facility as a leading center of excellence in the manufacturing of iPSCs and cell and gene therapies. He led the development of the world’s largest ALS iPSC and motor neuron biorepository for the Answer ALS program with over 1,200 iPSCs, distributed globally. The center he founded provides specializes in cGMP-compliant biomanufacturing services integrating cutting-edge automation technologies. He specializes in developing regenerative therapies for neural, vascular, pancreatic, and cardiac diseases with an emphasis to translate novel immune-evasive cell therapies. He is a prolific inventor with patents on stem cell reprogramming, differentiation and cell biomanufacturing technologies. He has published in high impact journals, investigating mechanisms underlying some of today’s most intractable diseases.

Presentation(s):